[Facing the evolutionary period for the treatment of rheumatoid arthritis].
Minota
Seiji
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D016861:Cyclooxygenase Inhibitors; D000069285:Infliximab